Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novaferon in hospitalized moderate to severe COVID-19
NCT04669015Phase 3Unknown
- Sponsor
- Genova
- Start
- Jun 2021
- Primary completion
- Aug 2022
- Modality
- Cytokines & Interferons
- Countries
- 12
01
Overview
A Phase 3 trial of novaferon in coronavirus disease 2019 (COVID-19), sponsored by Genova. Status: unknown.
02
Drugs
novaferon
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04669015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04669015.